Ciencia Puerto Rico

Will has started 4 medical device companies, raising nearly $40M in financing, returning money to investors with 2 exits (Sarif Biomedical and Lexington Technology Group) and positioning Microtransponder to complete large scale clinical studies in 2015 and IPO in 2016. HWill has 6 advanced graduate degrees that cover the failure modes inherent in translational neurotechnology. His PhD mode is in novel methods of wireless stimulation.

Currently, he is founder and CEO of Nexeon Medsystems, Inc.,a medical device manufacturer focused on the development of implantable therapies for the relief of chronic conditions.